Enable job alerts via email!
Boost your interview chances
Create a job specific, tailored resume for higher success rate.
Join a dynamic biopharmaceutical company that is committed to advancing innovative therapies in Endocrinology, Rare Disease, and Oncology. This role offers the opportunity to lead biostatistics activities, ensuring alignment with the company's objectives while collaborating with cross-functional teams. With a focus on exceptional science and a culture that fosters professional growth, you'll play a pivotal role in drug development, providing statistical guidance and ensuring timely delivery of analyses. If you are passionate about making a difference in patients' lives and thrive in a fast-paced environment, this position is perfect for you.
Ascendis Pharma is a dynamic, fast-growing global biopharmaceutical company with locations in Denmark, Europe, and the United States. Today, we're advancing programs in Endocrinology, Rare Disease, and Oncology.
Here at Ascendis, we pride ourselves on exceptional science, visionary leadership, and skilled and passionate colleagues.
Guided by our core values of Patients, Science, and Passion, we use our TransCon drug development platform to fulfill our mission of developing new and potentially best-in-class therapies to address unmet medical needs.
Our culture fosters a place where skilled, adaptable, and highly resourceful professionals can truly make their mark. We offer a dynamic workplace for employees to grow and develop their skills.
The individual in this position will provide leadership and execution of biostatistics activities associated with drug development to ensure that development activities are consistently aligned with the priorities and objectives of Ascendis Pharma. The role reports to the VP of Biostatistics and is based in Palo Alto.
Salary Range: $225-240K/year
We do not allow external search party solicitation. Presentation of candidates without written permission from the Ascendis Pharma HR team (specifically from a Talent Acquisition Partner or HR Director) is prohibited. Unauthorized submissions will not be acknowledged.